Autoimmune Vitiligo: Detection of Antibodies to Melanin-Producing Cells

New England Journal of Medicine

Volumn 297, Issue 12, 1977, Pages 634-637

  Hertz, Kenneth C ^a   Gazze, Laura A ^a   Kirkpatrick, Charles H ^a   Katz, Stephen I ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G;

ALOPECIA; AUTOIMMUNITY; CANDIDIASIS; COMPLEMENT FIXATION TEST; CYTOLOGY; DIAGNOSIS; ETIOLOGY; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MELANOCYTE; VITILIGO;

EID: 0017655768     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197709222971204     Document Type: Article

References (24)

1. Forcier RJ, Mclntyre OR, Frey WG, et al: Autoimmunity and multiple endocrine abnormalities. Arch Intern Med 129: 638–641, 1972
2. Doniach D, Grant D, Newns GH: Multi-endocrine autoimmune disorder in mother and son. Proc R Soc Med 65: 488–490, 1972
3. Burns-Cox CJ, Pearson JEG: Addison's disease, vitiligo, and multiple autoantibodies. Postgrad Med J 48: 115–117, 1972
4. Fisher M, Fitzpatrick TB: Candidiasis, vitiligo, Addison's disease, and hypoparathyroidism. Arch Dermatol 102: 110–112, 1970
5. Fields JP, Fragola L, Hadley TP: Hypoparathyroidism, candidiasis, alopecia, and vitiligo. Arch Dermatol 103: 687–689, 1971
6. McGregor BC, Katz HI, Doe RP: Vitiligo and multiple glandular insufficiencies. JAMA 219: 724–725, 1972
7. Cunliffe WJ, Hall R, Newell DJ, et al: Vitiligo, thyroid disease and autoimmunity. Br J Dermatol 80: 135–139, 1968
8. Lerner AB: Vitiligo. J Invest Dermatol 32: 285–310, 1959
9. Allison JR, Curtis achéal: Vitiligo and pernicious anemia. Arch Dermatol 72: 407–408, 1955
10. Dawber RPR: Integumentary associations of pernicious anaemia. Br J Dermatol 82: 221–223, 1970
11. Grunnet I, Howitz J, Reymann F, et al: Vitiligo and pernicious anemia. Arch Dermatol 101: 82–85, 1970
12. Dawber RPR: Clinical associations of vitiligo. Postgrad Med J 46: 276–277, 1970
13. Brostoff J, Bor S, Feiwel M: Autoantibodies in patients with vitiligo. Lancet 2: 177–178, 1969
14. Bor S, Feiwel M, Chanarin 1: Vitiligo and its aetiological relationship to organ-specific autoimmune disease. Br J Dermatol 81: 83–88, 1969
15. Howitz J, Schwartz M: Vitiligo, achlorhydria, and pernicious anaemia. Lancet 1: 1331–1335, 1971
16. Woolfson H, Finn OA, Mackie RM, et al: Serum anti-tumour antibodies and autoantibodies in vitiligo. Br J Dermatol 92: 395–400, 1975
17. Betterle C, Prete GFD, Peserico A, et al: Autoantibodies in vitiligo. Arch Dermatol 112: 1328, 1976
18. Katz SI, Hertz KC, Yaoita H: Herpes gestationis: immunopathology and characterization of the HG factor. J Clin Invest 57: 1434–1441, 1976
19. Falck B, Jacobson S, Olivecrona H, et al: Fluorescent dopa reaction of nevi and melanomas. Arch Dermatol 94: 363–369, 1966
20. Dobmeier LJ, Sams WM Jr: Autoimmunity in vitiligo. J Invest Dermatol 56: 410, 1971
21. Copeman PW, Lewis MG, Phillipps TM, et al: Immunological associations of the halo naevus with cutaneous malignant melanoma. Br J Dermatol 88: 127–137, 1973
22. Provost TT, Tomasi TB Jr: Evidence for complement activation via the alternate pathway in skin diseases. I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid. J Clin Invest 52: 1779–1787, 1973
23. Langhof H von, Feuerstein M, Schabinski G: Melaninantikorperbeldung bei Vitiligo. Hautarzt 5: 209–212, 1965
24. Birbeck MS, Breathnach AS, Everall JD: An electron microscope study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo. J Invest Dermatol 37: 51–64, 1961